Vigil Neuroscience, Inc.(VIGL)
8.05+0.000.00%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Vigil Neuroscience, Inc.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Vigil Neuroscience, Inc.于2020年6月22日根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，致力于通过开发疾病改善疗法来恢复小胶质细胞的警惕性，从而改善患有罕见和常见神经退行性疾病的患者、护理人员和家庭的生活。该公司的首批候选治疗药物旨在激活骨髓样细胞2上表达的触发受体（TREM2），这是一种关键的小胶质细胞受体蛋白，可介导对环境信号的反应，以维持大脑健康，其功能障碍与神经退化有关。该公司有两个主要的项目旨在针对TREM2。该公司的主要候选产品VGL101是一种全人源单克隆抗体（mAb）TREM2激动剂（或激活剂），目前正在一项2期概念验证试验中进行研究，该试验针对的是一种罕见且致命的神经退行性疾病——伴有轴索球体和色素胶质细胞（ALSP）的成人白质脑病患者。该公司的第二个项目专注于小分子TREM2激动剂，目前正在进行研究性新药（IND）授权研究。- 2025-08-05Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments员工持股计划Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-08-05Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments员工持股计划Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-08-05Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments员工持股计划Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-08-05Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments员工持股计划Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-08-05Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities交易所摘牌声明Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
- 2025-08-05Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-08-05Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-07-28Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-07-17Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-05-23Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-05-22Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-05-07Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-05-07Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-04-05Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2025-03-13Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
8.05
今开
8.05
量比
0.00
最低
8.05
昨收
8.05
换手率
0.00%